The rationale for development of ligelizumab in food allergy.
Wood RA, Chinthrajah RS, Eggel A, Bottoli I, Gautier A, Woisetschlaeger M, Tassinari P, Altman P.
Wood RA, et al. Among authors: eggel a.
World Allergy Organ J. 2022 Sep 13;15(9):100690. doi: 10.1016/j.waojou.2022.100690. eCollection 2022 Sep.
World Allergy Organ J. 2022.
PMID: 36185545
Free PMC article.
Review.